Kevin Manemann, chief executive, Providence Southern California, interviews Ora Gordon, MD, in a two-part series about exciting developments in the field of genetic research, including:

  • Changes in accessibility to genetic risk assessment (changing technology, driving down costs, insurance coverage)
  • Geno4ME (Genomic Medicine for Everyone) population genomics program implementation
  • GalleriTM  :One blood test for early detection of 50 cancers, and the Providence Galleri in Action study

In our January issue of Clinical Connections, we will share part two of this interview where you will learn about how cancers grow at a different pace and how molecular vulnerabilities of a tumor can determine how we treat a specific cancer.


Previous Article

Artificial Intelligence: Your fetal monitoring partner

Next Article
Meet Your Leaders
Meet Your Leaders

Rex Hoffman, MD, Chief Medical Officer at Providence Holy Cross and Chief Medical Officer, Clinical Institu...